Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction.
about
Therapy of the postinfectious irritable bowel syndrome: an update.What Is New in Rome IV.Association between self-reported vegetarian diet and the irritable bowel syndrome in the French NutriNet cohort.Intractable Constipation in the Elderly.Pros and Cons While Looking Through an Asian Window on the Rome IV Criteria for Irritable Bowel Syndrome: Pros.Dexloxiglumide for the treatment of constipation predominant irritable bowel syndrome.Neuroimmune factors in functional gastrointestinal disorders: A focus on irritable bowel syndrome.An expert consensus definition of failure of a treatment to provide adequate relief (F-PAR) for chronic constipation - an international Delphi survey.Update on Rome IV Criteria for Colorectal Disorders: Implications for Clinical Practice.Sex-Related Differences in GI Disorders.Irritable bowel syndrome in Asia: pathogenesis, natural history, epidemiology and management.Irritable bowel symptoms and the development of common mental disorders and functional somatic syndromes identified in secondary care - a long-term, population-based study.Low Prevalence of Clinically Significant Endoscopic Findings in Outpatients with Dyspepsia.Western Dietary Pattern Is Associated with Irritable Bowel Syndrome in the French NutriNet CohortColonic Transit Time and Gut Peptides in Adult Patients with Slow and Normal Colonic Transit Constipation.Subthreshold Psychiatric Psychopathology in Functional Gastrointestinal Disorders: Can It Be the Bridge between Gastroenterology and Psychiatry?Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide.Sexual Abuse Is Associated With an Abnormal Psychological Profile and Sleep Difficulty in Patients With Irritable Bowel Syndrome in Taiwan.Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome.Gender and Weight Influence Quality of Life in Irritable Bowel Syndrome.The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation.Critical appraisal of Rome IV criteria: hypersensitive esophagus does belong to gastroesophageal reflux disease spectrum.The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries.Harnessing Gut Microbes for Mental Health: Getting From Here to There.Effect of Lactobacillus rhamnosus GG supernatant on serotonin transporter expression in rats with post-infectious irritable bowel syndrome.Impact of Comorbid Irritable Bowel Syndrome on Treatment Outcome in Non-Erosive Reflux Disease on Long-Term Proton Pump Inhibitor in Japan.Determining an optimal dose of linaclotide for use in Japanese patients with irritable bowel syndrome with constipation: A phase II randomized, double-blind, placebo-controlled study.Lactobacillus acidophilus and Bifidobacterium longum supernatants upregulate the serotonin transporter expression in intestinal epithelial cells.Research Design Characteristics of Published Pharmacologic Randomized Clinical Trials for Irritable Bowel Syndrome and Chronic Pelvic Pain Conditions: an Acttion Systemic Review.Connecting Our Gut Feeling and How Our Gut Feels: The Role of Well-being Attributes in Irritable Bowel Syndrome.Female-specific Association Between Variants on Chromosome 9 and Self-reported Diagnosis of Irritable Bowel Syndrome.Illness Perception of Patients with Functional Gastrointestinal Disorders.A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies.Pediatric abdominal migraine: current perspectives on a lesser known entity.Management of gastroesophageal reflux disease in adults: a pharmacist’s perspective.A Randomized Controlled Trial of Chinese Patent Medicine Xiao'er Biantong Granules in the Treatment of Functional Constipation in Children.Minor digestive symptoms and their impact in the general population: a cluster analysis approach.Fecal Calprotectin: A Comparison of Two Commercial Enzymoimmunoassays and Study of Fecal Extract Stability at Room Temperature.Association Between Alexithymia and Functional Gastrointestinal Disorders.Understanding Neurogastroenterology From Neuroimaging Perspective: A Comprehensive Review of Functional and Structural Brain Imaging in Functional Gastrointestinal Disorders
P2860
Q33693294-8ACDAE95-CBDA-4794-8033-4B007168F8B7Q34680985-AB94ACCC-1D16-4164-A50E-A70A04414C1DQ38608122-BF96960D-E7D6-4C75-B0FC-2A3C991D8762Q38628027-F5BC04C7-A753-499F-9FCF-1653752CFD49Q38696423-F107ADC5-23BB-4D22-9430-9E4CD8EA9478Q38824780-401C5EDA-F378-4EDA-8034-3B43902EBBD3Q39058964-64DB1467-2311-4FAF-83AE-DC87C3FB4354Q39137380-ACCB4910-EEE5-47D5-A6CB-BB90DE2376BAQ39218204-0B595F49-7503-4F67-9F03-72187F2491FDQ39303889-49F88EBE-7136-4007-ADCF-040C551B19E3Q40044036-3900C034-FB80-4B1D-9D06-3A2AF053A7B7Q41276690-FF865700-E7D9-4E6C-B099-587E5682C45CQ42067910-8641BA05-F10D-4D66-B630-C0ADA0F034E6Q42097714-68D81696-7A70-4784-999C-13FA2377CA6BQ42730653-4F8CB526-2FF8-4624-AC35-4900D009B325Q45471839-EF6220CD-71AD-4EFF-BE5A-6E4092B89944Q45842056-C3FDFB2C-6BB6-4129-9366-103FA83A4BEAQ47100912-7EC402A9-F085-4E67-91B2-DAD13C3FA2AAQ47135887-5C06D66F-489F-4F16-A874-8302F19F8185Q47177925-ED7B98CC-6336-4436-AF32-CEED5646389BQ47179802-FA6CDE79-606A-4A4A-8A88-EA0BABF1E7FFQ47422883-6D09463F-B018-49D2-BD98-0898796D8142Q47574638-08D8563A-F2F1-47E5-B580-2753FD845A04Q47597532-FBAA4F9F-4ED1-4D89-88F8-AD5F73605D44Q47825106-FF2BC299-C113-4F92-8C31-C7F70652C23FQ47847807-9B045897-B330-4130-916B-DE38C5373769Q48349012-E421BB53-7CED-4DB9-A897-C709756035E1Q49940453-4787A86F-AD34-458F-B9A4-6E01C44968ECQ50107982-9DBB60E6-85F9-4CAD-AE2F-14120DE4A008Q51415182-E759CC71-9A56-47D7-A60E-817D8F37F4BEQ52329363-6A0F6CF8-E17D-4B1B-A03F-640CB92C8D30Q52803978-BB9CC056-B9AD-450F-9DF9-A34A840F5B1BQ54263480-0F01B5E2-9AD6-46D0-A91F-7CF7176D7D23Q54944697-6ECF12D1-FEEA-4F99-9E4B-C7807DE140FAQ55001719-47831C8D-B95F-4558-8304-2F73F533D045Q55035786-FC95DAA4-AB0D-43E3-8E3D-BE189C8AA2E3Q55054950-FE4D3C4D-4225-439F-9BF3-594BFB25D67FQ55397418-DDECF1F9-16D9-4E04-9252-4BCBF347908DQ55471560-F1B602DC-0D4E-4C94-958B-E9891EC97B2CQ57174938-4942876C-E92A-4069-A9C9-822557F22242
P2860
Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction.
@ast
Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction.
@en
Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction.
@nl
type
label
Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction.
@ast
Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction.
@en
Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction.
@nl
prefLabel
Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction.
@ast
Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction.
@en
Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction.
@nl
P1433
P1476
Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction.
@en
P2093
Douglas A Drossman
William L Hasler
P304
P356
10.1053/J.GASTRO.2016.03.035
P407
P577
2016-05-01T00:00:00Z